Kymera Therapeutics

Kymera Therapeutics Strengthens Leadership with Key Appointments and Promotions

WATERTOWN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointments of Ashwin Gollerkeri, MD, as Senior Vice